Overview
- Mexico’s latest epidemiological bulletin confirms nearly 16,000 new HIV cases in 2025, with 180,319 recorded over the past decade and a significant share among people aged 15–24.
- In Argentina, 45% of new HIV diagnoses are late and about 13% of people living with the virus are unaware of their status.
- More than 98% of infections in Argentina are linked to unprotected sex, spurring expanded free rapid testing campaigns this week across Buenos Aires province.
- Mexico has designated dolutegravir/lamivudine as the preferred public regimen for 2025–2026, aiming to maintain efficacy with a two‑drug single tablet and reduce long‑term toxicity.
- UNAIDS cites OECD projections of a 30–40% drop in external funding versus 2023 and reports service disruptions, while stigma continues to delay timely diagnosis and care.